Abstract
EGFRvIII is a constitutively activated truncated variant of the epidermal growth factor receptor (EGFR) which has been shown to increase tumorgenicity. There are conflicting reports on the extent of EGFRvIII expression in tissues which may in part stem from the use of different assay methodologies. We investigated the expression of both EGFRvIII and wild-type EGFR (EGFRwt) in cell lines and primary breast cancers. First, we used a RT-PCR assay that can simultaneously measure EGFRwt and EGFRvIII mRNA to screen 55 tumor cell lines. We show that except for EGFRvIII transfected cells, only EGFRwt was detected. We then validated a real-time PCR assay and used this to screen 170 formalin fixed paraffin-embedded primary breast cancers for evidence of EGFRwt and EGFRvIII expression. No samples were positive for EGFRvIII expression except for control transfectants and glioblastomas. In contrast, EGFRwt was expressed at varying levels in the majority of samples tested. We conclude that the expression of EGFRvIII is extremely rare in breast cancer and therefore it does not contribute to the malignant phenotype.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carpenter G, Cohen S: Epidermal growth-factor. J Bio Chem 265: 7709–7712, 1990
Kim ES, Khuri FR, Herbst RS: Epidermal growth factor receptor biology (IMC-C225). Curr Opin Oncol, 13: 506–513, 2001
Arteaga CL: The epidermal growth factor receptor: from mutant oncogene in nonhuman cancers to therapeutic target in human neoplasia. J Clin Oncol 19: 32S–40S, 2001
Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M: Amplification of the structur-ally and functionally altered epidermal growth-factor receptor gene (C-Erbb) in human-brain tumors. Mol Cell Biol 8: 1816–1820, 1988
Ekstrand AJ, Sugawa N, James CD, Collins VP: Amplified and rearranged epidermal growth-factor receptor genes in human glioblastomas reveal deletions of sequences encod-ing portions of the N-terminal and or C-terminal tails. Proc Natl Acad Sci USA 89: 4309–4313, 1992
Wong AJ, Ruppert JM, Bigner SH, Grzeschik CH, Hum-phrey PA, Bigner DS, Vogelstein B: Structural alterations of the epidermal growth-factor receptor gene in human gliomas. Proc Natl Acad Sci USA 89: 2965–2969, 1992
Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humphrey PA, Kurpad SN, McLendon RE, Moscatello D, Pegram CN, Reist CJ, Traweek ST, Wong AJ, Zalutsky MR, Bigner DD: Monoclonal-antibodies against EGFRvIII are tumor-specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res 55: 3140–3148, 1995
Moscatello DK, Holgadomadruga M, Godwin AK, Ramirez G, Gunn G, Zoltick PW, Biegel JA, Hayes RL, Wong AJ: Frequent expression of a mutant epidermal growth-factor receptor in multiple human tumors. Cancer Res 55: 5536–5539, 1995
Ge H, Gong X, Tang CK: Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissec-tion and immunohistochemical analysis. Int J Cancer 98: 357–361, 2002
Jungbluth AA, Stockert E, Huang HJ, Collins VP, Coplan K, Iversen K, Kolb D, Johns TJ, Scott AM, Gullick WJ, Ritter G, Cohen L, Scanlan MJ, Cavanee WK, Old LJ: A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor. Proc Natl Acad Sci USA 100: 639–644, 2003
Tidow N, Boecker A, Schmidt H, Agelopoulos K, Boecker W, Buerger H, Brandt B: Distinct ampli cation of an untranslated regulatory sequence in the EGFR gene con-tributes to early steps in breast cancer development. Cancer Res 63: 1172–1178, 2003
Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME: Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Cancer Res 60: 3081–3087, 2000
Luo X, Gong X, Tang CK: Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme. Int J Cancer 104: 716–721, 2003
Bustin SA: Absolute quanti cation of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endo 25: 169–193, 2000
Cronin M, Pho M, Dutta D, Stephans JC, Shak S, Kiefer MC, Esteban J, Baker JB: Measurement of gene expression in archival para fin-embeded tissues: development and performance of a 92 Gene RT-PCR Assay. Am J Path 164(1): 35–42, 2004
Morris T, Robertson B, Gallagher M: Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system. J Clin Micro 34: 2933–2936, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rae, J.M., Scheys, J.O., Clark, K.M. et al. EGFR and EGFRvIII Expression in Primary Breast Cancer and Cell Lines. Breast Cancer Res Treat 87, 87–95 (2004). https://doi.org/10.1023/B:BREA.0000041585.26734.f9
Issue Date:
DOI: https://doi.org/10.1023/B:BREA.0000041585.26734.f9